To view this email as a web page, click here.
 
COMMUNITY REPORT
Gottlieb Tapped for FDA Commissioner Spot
Former FDA deputy commissioner is nominated for the top job, but financial ties may bind.
Read more
 
ADVERTISEMENT
 
POPULAR ON THE WEB
 
Cardiac Matters
A closer look at Cangrealor (Kengreal)
 
You're a Pharmacist, not a Physician: Get Your Own Title
Pharmacists and physicians—what's the difference?
 
More States Mandate Prescription Drug Monitoring Programs
How PDMPs are helping to quell the prescription drug abuse crisis.
 
EDITOR'S CHOICE
FDA Approves Drug for Treatment of Nocturnal Polyuria
Noctiva is the first agent approved to temporarily decrease urine production in adults with nocturia from various causes.
Read more
 
ADVERTISEMENT
 
INSIDE THE LATEST ISSUE
 
Considering Specialty Pharmacy? Make Your Move
image description here Specialty drugs are a booming market, but time is running short for any chain or independent pharmacies to enter.

 
CONTINUING EDUCATION
 
Human papillomavirus (HPV) vaccine: Updated recommendations and strategies to improve
New Options When Statins Are Not Enough
Key cogs in the management of Parkinson's disease
 
DIGITAL EDITION
February 2017 | Vol. 161 No. 2
In this issue, find out what a Trump administration could mean for you, and take another look at specialty pharmacy before it's too late. We also take a look at the importance of standardization and discuss food interactions.
Read the whole issue here
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.